Literature DB >> 3211819

Serious complications following treatment of chronic idiopathic thrombocytopenic purpura.

W Wanachiwanawin1, S Visudhiphan, A Piankijagum, S Vatanavicharn.   

Abstract

Six patients had serious complications as consequences of treatment of idiopathic thrombocytopenic purpura. Five had splenectomy-related complications, one of them developed fatal intra-abdominal bleeding. Three patients acquired operation-related serious infection, two of them died. Serious neutropenia after vinblastine-loaded platelets occurred in one patient leading to pseudomonas septicaemia and panophthalmitis with permanent vision loss of left eye. Recurrence thrombocytopenia occurred in every case during serious complications. Early detection by awareness of the possibility of serious complications can reduce morbidity and mortality occurring after therapy of idiopathic thrombocytopenic purpura.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3211819      PMCID: PMC2428857          DOI: 10.1136/pgmj.64.752.426

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

Review 1.  Autoimmune thrombocytopenic purpura.

Authors:  S Karpatkin
Journal:  Semin Hematol       Date:  1985-10       Impact factor: 3.851

Review 2.  Autoimmune thrombocytopenic purpura.

Authors:  S Karpatkin
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

3.  The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets.

Authors:  Y S Ahn; J J Byrnes; W J Harrington; M L Cayer; D S Smith; D E Brunskill; L M Pall
Journal:  N Engl J Med       Date:  1978-05-18       Impact factor: 91.245

Review 4.  Treatment of chronic immune thrombocytopenia.

Authors:  W F Rosse
Journal:  Clin Haematol       Date:  1983-02

Review 5.  Chronic idiopathic thrombocytopenic purpura.

Authors:  R McMillan
Journal:  N Engl J Med       Date:  1981-05-07       Impact factor: 91.245

6.  Splenectomy for idiopathic thrombocytopenic purpura.

Authors:  G E Block; R Evans; R Zajtchuk
Journal:  Arch Surg       Date:  1966-04

7.  Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.

Authors:  S Sukenik; A el-Roeiy; Y Shoenfeld
Journal:  Acta Haematol       Date:  1986       Impact factor: 2.195

Review 8.  Treatment of idiopathic thrombocytopenic purpura (ITP).

Authors:  Y S Ahn; W J Harrington
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

9.  Danazol for the treatment of idiopathic thrombocytopenic purpura.

Authors:  Y S Ahn; W J Harrington; S R Simon; R Mylvaganam; L M Pall; A G So
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

10.  Idiopathic thrombocytopenic purpura.

Authors:  T R Burns; A Saleem
Journal:  Am J Med       Date:  1983-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.